Poly-d,l-Lactic Acid Via Transdermal Microjet Drug Delivery for Treating Rosacea in Asian Patients.

Background: Rosacea, a chronic inflammatory skin condition, is marked by enduring redness, visible blood vessels, and inflammatory eruptions in facial areas. Managing rosacea remains a persistent challenge for dermatologists, especially in cases unresponsive to conventional treatments. Injectable poly-d,l-lactic acid (PDLLA) has shown promise in treating erythema and telangiectasia associated with rosacea in addition to age-related concerns.

[Iatrogenic loss of vision by aesthetic treatment with filler].

Facial treatment with hyaluronic acid-containing fillers is one of the most popular non-surgical aesthetic treatment procedures, and severe complications are generally rare. However, one of the most feared complications is vascular compromise with visual loss. In this case report, a treatment and handling algorithm based on casuistic data is presented for emergency use in this catastrophic situation, since prompt and sufficient action is essential.

Iatrogenic vision loss following aesthetic treatment with hyaluronic acid-containing filler: Every injector should be prepared.

Facial aesthetic enhancement with a hyaluronic acid-containing filler is a minimally invasive procedure that is considered rather safe. However, the most feared complications include vascular compromise and development of blindness. When vision loss occurs, prompt and sufficient action is essential.

Expert Consensus on Injection Technique and Area-Specific Recommendations for the Hyaluronic Acid Dermal Filler VYC-12L to Treat Fine Cutaneous Lines.

Background: VYC-12L is a hyaluronic acid (HA) injectable gel designed to treat fine cutaneous lines and improve skin quality attributes such as hydration and elasticity.

Objective: Expert consensus was sought on VYC-12L injection technique and primary treatment target areas.

Methods: A multinational group of aesthetic medicine clinicians (n = 128) attended product training and each identified ~10 patients for VYC-12L.

Corneal endothelial cell changes after cataract surgery in patients on systemic sympathetic α-1a antagonist medication (tamsulosin).

Purpose:   The purpose of this study was to assess the incidence of intraoperative floppy iris syndrome (IFIS) and the morphology of the corneal endothelium after cataract extraction in Caucasian male patients exposed to the α-1a adrenergic receptor antagonist tamsulosin.

Methods:   In a clinical prospective study, 23 male patients (23 eyes) treated with tamsulosin due to benign prostatic hyperplasia and 25 male patients (25 eyes) with no tamsulosin treatment had cataract surgery. The divide-and-conquer technique was used with the Infinity OZil(®) machine.